Kerecis
Kerecis is a commercial stage company pioneering the use of fish skin and fatty acids in cellular-therapy and regenerative-medicine
Kerecis operates in health care, manufacturing, medical, medical device based in Nordic Countries, Scandinavia, Europe, Middle East, and Africa (EMEA), founded in 2009.
Kerecis is positioned in health care, manufacturing, medical, medical device, a segment that rewards a clear, focused offering.
The company is recorded as being based in Nordic Countries, Scandinavia, Europe, Middle East, and Africa (EMEA).
It is recorded at the Series_D stage.
The company reports a headcount in the c_00501_01000 range.
Total disclosed funding stands at about $123.6M.
| Sector | Health Care, Manufacturing, Medical, Medical Device |
|---|---|
| Headquarters | Nordic Countries, Scandinavia, Europe, Middle East, and Africa (EMEA) |
| Founded | 2009 |
| Employees | c_00501_01000 |
| Stage | series_d |
| Total funding | $123,611,641 |
Website: www.kerecis.com
Browse related
Emails and contact routes are reserved for registered members.
Create a free account
Create a free account